Relay Therapeutics (RLAY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec12

Relay Therapeutics Reports Encouraging Interim Results for Zovegalisib in Advanced Breast Cancer Trial

12:00

Nov7

US Bank Securities Maintains Buy Rating for Relay Therapeutics

12:42

Relay Therapeutics released FY2025 9 Months Earnings on November 6, After-Market EST, with actual revenue of USD 8.356 M and EPS of USD -1.2964

00:00

Relay Therapeutics released FY2025 Q3 earnings on November 6 After-Market (EST), actual revenue USD 0 (forecast USD 113.33K), actual EPS USD -0.4301 (forecast USD -0.413)

00:00

Oct30

Relay Therapeutics to Release FY2025 Q3 Earnings on November 6 After-Market (EST), Forecast Revenue USD 160K, EPS USD -0.406

00:07

Aug7

Relay Therapeutics released FY2025 Q2 earnings on August 7 After-Market EST: Actual Revenue USD 677K (Forecast USD 75K), Actual EPS USD -0.4109 (Forecast USD -0.49)

23:00